Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
33 studies found for:    Open Studies | "Adrenal Hyperplasia, Congenital"
Show Display Options
Rank Status Study
21 Recruiting Suppression of Daytime and Nighttime Luteinizing Hormone Frequency by Progesterone
Conditions: Polycystic Ovary Syndrome;   Hyperandrogenism;   Normal Puberty
Interventions: Drug: Progesterone;   Drug: Placebo
22 Unknown  Effect of Metformin on Sensitivity of the Gonadotropin-releasing Hormone (GnRH) Pulse Generator to Suppression by Estradiol and Progesterone
Conditions: Polycystic Ovary Syndrome;   Hyperandrogenism
Interventions: Drug: Metformin;   Drug: Progesterone;   Drug: estrace
23 Unknown  Effect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess
Conditions: Obesity;   Hyperandrogenemia;   Polycystic Ovary Syndrome
Interventions: Drug: Spironolactone;   Drug: Dexamethasone;   Drug: Cosyntropin;   Drug: r-hCG (Ovidrel)
24 Unknown  Effect of Metformin on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess
Conditions: Obesity;   Hyperandrogenemia;   Polycystic Ovary Syndrome
Interventions: Drug: Metformin;   Drug: Dexamethasone;   Drug: Cosyntropin;   Drug: r-hCG (Ovidrel)
25 Unknown  Effect of Short Term Adrenal Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess
Conditions: Hyperandrogenemia;   Obesity;   Polycystic Ovary Syndrome
Interventions: Drug: Hydrocortisone;   Drug: dexamethasone;   Drug: Cosyntropin (ACTH)
26 Unknown  Effect of Short Term Ovarian Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess
Conditions: Hyperandrogenemia;   Obesity;   Polycystic Ovary Syndrome
Interventions: Drug: Leuprolide;   Drug: Dexamethasone;   Drug: recombinant human chorionic gonadotropin
27 Unknown  Ovarian Contribution to Androgen Production in Adolescent Girls
Conditions: Polycystic Ovary Syndrome;   Obesity;   Hyperandrogenism
Interventions: Drug: Dexamethasone;   Drug: r-hCG (Ovidrel)
28 Recruiting Time Course of Waking Versus Sleep-associated Luteinizing Hormone (LH) Pulse Frequency Suppression in Response to Progesterone in Late Pubertal Girls With and Without Hyperandrogenemia
Conditions: Puberty;   Hyperandrogenism
Interventions: Drug: Micronized progesterone suspension;   Drug: Placebo
29 Recruiting Etiological Factors of Obesity-Associated Hyperandrogenemia in Peripubertal Girls
Conditions: Obesity;   Hyperandrogenemia;   Polycystic Ovary Syndrome
Intervention:
30 Unknown  Whole Genome Analysis for the Detection of Key Genes in the Polycystic Ovary Syndrome
Conditions: Anovulation;   Hyperandrogenism;   Polycystic Ovary Syndrome;   Single Nucleotide Polymorphism
Intervention:
31 Recruiting Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers
Conditions: Schizophrenia;   Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorder With Hyperactivity
Intervention:
32 Recruiting A European Post-Authorisation Observational Study (Registry) of Patients With Chronic Adrenal Insufficiency
Condition: Chronic Adrenal Insufficiency
Intervention:
33 Recruiting Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome
Conditions: Cushing's Syndrome,;   Ectopic Corticotropin Syndrome,;   Adrenal Adenoma,;   Adrenal Carcinoma,;   AIMAH,;   PPNAD
Intervention: Drug: Osilodrostat

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-33) Next Page   
Indicates status has not been verified in more than two years